All In MedTech

FDA Clearance Tracker · P100026-S091

NeuroPace® RNS® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 29, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 29, 2022

Approved

Time to decision

94 days

Received Sep 26, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100026-S091
Device name
NeuroPace® RNS® System
Applicant location
Mountain View, CA
Received
Sep 26, 2022
Decided
Dec 29, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100026

Device type

Device class
Class III

Every decision under product code PFN

FDA's approval statement

As written in FDA's record.

Approval to use a second contract sterilizer for the ethylene oxide (EO) sterilization of RNS System products.

Source documents

Other decisions for NeuroPace, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.